Householder Group Estate & Retirement Specialist’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$80K Sell
3,015
-4,278
-59% -$116K 0.06% 174
2024
Q3
$211K Sell
7,293
-1,744
-19% -$50.9K 0.06% 238
2024
Q2
$252K Sell
9,037
-680
-7% -$18.7K 0.07% 214
2024
Q1
$270K Buy
9,717
+399
+4% +$11.1K 0.08% 200
2023
Q4
$268K Buy
9,318
+150
+2% +$4.53K 0.09% 203
2023
Q3
$304K Buy
+9,168
New +$324K 0.11% 161
2023
Q1
$412K Buy
+10,097
New +$436K 0.16% 123
2022
Q4
Sell
-9,468
Closed -$414K 874
2022
Q3
$414K Buy
9,468
+2
+0% +$97 0.17% 125
2022
Q2
$496K Buy
9,466
+986
+12% +$50.2K 0.22% 110
2022
Q1
$439K Buy
8,480
+506
+6% +$26.3K 0.18% 130
2021
Q4
$471K Buy
+7,974
New +$395K 0.18% 131

Other funds holding PFE

Householder Group Estate & Retirement Specialist's PFE Position: Q4 2024 in Review

Householder Group Estate & Retirement Specialist reduced its Pfizer (PFE) stake by 59% in Q4 2024, selling an estimated $116K and leaving 3,015 shares worth $80K. The position accounts for 0.06% of the portfolio, ranked #174.

Householder Group Estate & Retirement Specialist first reported a position in PFE in Q4 2021 and has held it in 11 quarters since. The position peaked at $496K in Q2 2022. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Householder Group Estate & Retirement Specialist held 3,015 shares of Pfizer worth $80K as of Q4 2024.
  • Householder Group Estate & Retirement Specialist sold 4,278 Pfizer shares in Q4 2024, an estimated $116K.
  • Pfizer made up 0.06% of Householder Group Estate & Retirement Specialist's portfolio in Q4 2024, its #174 holding.
  • Householder Group Estate & Retirement Specialist first reported a position in Pfizer in Q4 2021 and has held it in 11 quarters since.
  • Householder Group Estate & Retirement Specialist's Pfizer position peaked at $496K in Q2 2022.
  • 2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2024, filed 15 Jan 2025.